Compare OPTT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | XTNT |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 82.6M |
| IPO Year | 2007 | N/A |
| Metric | OPTT | XTNT |
|---|---|---|
| Price | $0.34 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.50 | $1.50 |
| AVG Volume (30 Days) | ★ 3.7M | 241.1K |
| Earning Date | 12-15-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $3,748,000.00 | ★ $133,083,000.00 |
| Revenue This Year | $70.98 | $15.08 |
| Revenue Next Year | $106.21 | N/A |
| P/E Ratio | ★ N/A | $69.41 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $0.30 | $0.34 |
| 52 Week High | $1.75 | $0.95 |
| Indicator | OPTT | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 56.10 |
| Support Level | $0.30 | $0.75 |
| Resistance Level | $0.38 | $0.81 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 27.61 | 60.30 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.